Skip to main navigation

Investors + Newsroom
Culture + Careers

Who We Are

Who We Are
Science & Innovation

Science & Innovation
Therapeutic Pipeline

Therapeutic Pipeline
Patients & Families

Patients & Families

Search
Investors + Newsroom
Culture + Careers

Events & Presentations

Overview
News
Events + Presentations
Stock Information
Sec Filings
Corporate Governance
Shareholder Services

Featured Presentations

Corporate Presentation Data Publications

RGX-202: AFFINITY DUCHENNE® Pivotal Trial and Interim Functional Data 2.1 MB

REGENXBIO New Interim Clinical Data from the Phase I/II AFFINITY DUCHENNE® Trial Presentation; MDA 2024 1.3 MB

REGENXBIO Rare Disease Program Update Presentation 704.9 KB

REGENXBIO Interim Data Update from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery Presentation; Hawaiian Eye and Retina 2024 990 KB

REGENXBIO Interim Data Update from Phase II ALTITUDE® Trial of ABBV-RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery Presentation - AAO 2023 956.8 KB

Upcoming Events

More events are coming soon.

Past Events

Dec 05, 2024 at 9:30 AM EST

Piper Sandler 36th Annual Healthcare Conference

Click here for webcast

Nov 19, 2024 at 11:30 AM EST

Stifel 2024 Healthcare Conference

Click here for webcast

Nov 18, 2024 at 8:00 AM EST

AFFINITY DUCHENNE Trial of RGX-202: Pivotal Program and Interim Clinical Data

click here for webcast

Nov 14, 2024

B. Riley Securities Next-Gen Tissue Delivery Modalities Summit

Nov 13, 2024 at 12:30 PM PST

UBS Global Healthcare Conference

Click here for webcast

Nov 06, 2024 at 4:30 PM EST

Q3 2024 REGENXBIO Inc. Earnings Conference Call

Click here for webcast

Sep 30, 2024 at 8:30 AM EDT

Chardan's 8th Annual Genetic Medicines Conference

Click here for webcast

Sep 11, 2024 at 9:40 AM EDT

Baird 2024 Global Healthcare Conference

click here for webcast

Sep 05, 2024 at 5:35 PM EDT

Morgan Stanley 22nd Annual Global Healthcare Conference

click here for webcast

Aug 15, 2024 at 9:00 AM EDT

H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

Click here for webcast

Pagination

Current page 1
Page 2
Next page
Last page

Contact Us

Stay connected on REGENXBIO programs and our commitment to patients.

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy.

Contact Us

Terms and Conditions

Privacy Policy

© 2025 Regenxbio Inc. • "NAV®" is a registered trademark of REGENXBIO Inc. • All Rights Reserved